Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Membrane alterations associated with hemoglobinopathies

W N Jensen, L S Lessin

    Seminars in Hematology
    |October 1, 1970
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical application of recombinant erythropoietin in myelodysplasia.

    Hematology/oncology clinics of North America·1994
    Same author

    Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation.

    British journal of haematology·1994
    Same author

    Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study.

    The American journal of pediatric hematology/oncology·1994
    Same author

    Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory process.

    European journal of clinical investigation·1994
    Same author

    High Ia (HLA-DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes.

    American journal of hematology·1993
    Same author

    Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study.

    Cancer·1993
    Same journal

    Pain in SCD-Many mechanisms and mysteries.

    Seminars in hematology·2026
    Same journal

    The many facets of cardiopulmonary complications in sickle cell disease.

    Seminars in hematology·2026
    Same journal

    Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

    Seminars in hematology·2026
    Same journal

    Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

    Seminars in hematology·2026
    Same journal

    Telomeres biology disorders: the past, the present and the future.

    Seminars in hematology·2026
    Same journal

    Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

    Seminars in hematology·2026
    See all related articles